Bausch + Lomb BLCO Vision Care — Operating Income (Loss)

Other segment segments

Similar metrics at other companies

COOCooperVision — Operating Income (Loss)

$215.6M+15.7%

CHE

CHESegment Vitas — Operating Income

$62.45M-0.5%

BDXConnected Care — Operating Income (Loss)

$347M-1.7%

CLOral Personal And Home Care — Operating Income (Loss)

$1.03B+6.1%

DHRLife Sciences — Operating Income (Loss)

$225M+11.9%

VSATCommunication Services — Operating Income

$2.26M+102%

Questions, answered.

What is Bausch + Lomb's vision care — operating income (loss)?

Bausch + Lomb (BLCO) reported vision care — operating income (loss) of $202M in Q1 2026.

How has Bausch + Lomb's vision care — operating income (loss) changed year-over-year?

Bausch + Lomb's vision care — operating income (loss) increased by 14.8% year-over-year, from $176M to $202M.

What is the long-term trend for Bausch + Lomb's vision care — operating income (loss)?

Over 4 years (2021 to 2025), Bausch + Lomb's vision care — operating income (loss) has grown at a 10.2% compound annual growth rate (CAGR), from $576M to $849M.

What does vision care — operating income (loss) mean?

Calculated as the segment's total revenue minus its direct operating expenses, including R&D and SG&A. This metric provides a clear view of the core profitability of the Vision Care business before interest and taxes. It is the primary benchmark for assessing the operational efficiency and margin performance of the segment.